Carl Zeiss Meditec Group’s H1 2023/24 Financial and Operational Performance Overview In a compelling presentation, the CEO and CFO of Carl Zeiss Meditec Group detailed the company’s financial and operational performance for the first half of the fiscal year 2023/24. Addressing a professional audience of stock investors, they revealed a nuanced picture of the company’s unwavering resilience and strategic manoeuvres in a challenging economic landscape, instilling a sense of stability and trust. CEO’s Overview of Global Economic Impact on Performance The video opens with the CEO, Dr. Markus Weber, summarizing the global economic conditions and their impact on the company. He notes a slight decrease in revenue to €947.2 million, attributing it to factors like geopolitical tensions, which affected our international sales, and supply chain disruptions, which led to production delays. Despite these challenges, strategic business units like Microsurgery showed remarkable growth, signalling robust demand and operational efficiency. CFO’s Detailed Financial Analysis The CFO, Justus Felix Wehmer, then takes viewers through a detailed financial analysis, highlighting a decrease in EBIT to €108.2 million and a consolidated profit of €83.9 million. He emphasizes the strategic investments in R&D and marketing, which are crucial for long-term growth despite short-term cost pressures. Strategic Developments and Projections Significant developments, such as the acquisition of DORC BV, are discussed, underscoring Carl Zeiss Meditec’s proactive expansion in ophthalmic surgical devices. Both leaders expressed a strong sense of cautious optimism for the second half of the fiscal year, forecasting a recovery in EBIT margins and revenue growth, fuelled by strategic initiatives and market expansions, fostering a positive outlook in the audience. ▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com